https://pharmadog.xyz/news/450671 pharmadog en 2026-09-24T20:21:32.000Z STAT+: FDA commissioner nominee Heidi Overton keeps opinions to herself in Senate hearing https://pharmadog.xyz/news/450503 pharmadog en 2026-09-24T19:30:38.000Z STAT's The Readout LOUD podcast goes international with a Shanghai dispatch on China's biotech surge https://pharmadog.xyz/news/450315 pharmadog en 2026-09-24T18:53:03.000Z FDA warns Houston compounding pharmacy of unsanitary GLP-1 production risking contamination https://pharmadog.xyz/news/450075 pharmadog en 2026-09-24T17:08:50.000Z Elevar Therapeutics receives FDA approval for Lyrfigtu as second-line treatment for bile duct cancer https://pharmadog.xyz/news/449951 pharmadog en 2026-09-24T16:38:12.000Z Senate Finance Committee Advances Chris Klomp’s HHS Deputy Nomination https://pharmadog.xyz/news/449803 pharmadog en 2026-09-24T15:34:00.000Z Merck's remigromig meets visual acuity goal in diabetic macular edema trial, safety signals noted https://pharmadog.xyz/news/449739 pharmadog en 2026-09-24T15:30:48.000Z Roche signs discovery partnerships with Atavistik Bio and Earendil Labs https://pharmadog.xyz/news/449740 pharmadog en 2026-09-24T15:05:48.000Z Sarepta Therapeutics agrees to pay $39 million to settle gene therapy dispute with Regenxbio https://pharmadog.xyz/news/449615 pharmadog en 2026-09-24T14:57:54.000Z Indonesian court strikes down patent evergreening amendment, signaling pushback on drug pricing tactics https://pharmadog.xyz/news/449571 pharmadog en 2026-09-24T14:50:01.000Z Acadia’s Alzheimer’s psychosis drug misses Phase 2 goals, but moves to revised Phase 3 https://pharmadog.xyz/news/449572 pharmadog en 2026-09-24T14:32:38.000Z Heidi Overton, Trump’s FDA commissioner nominee, to face Senate confirmation hearing https://pharmadog.xyz/news/449573 pharmadog en 2026-09-24T14:26:11.000Z AI doomsday warnings may curb health-tech innovation, Epic cautions https://pharmadog.xyz/news/449595 pharmadog en 2026-09-24T14:25:32.000Z Acadia’s Alzheimer’s psychosis drug misses primary goal but advances on secondary data https://pharmadog.xyz/news/449635 pharmadog en 2026-09-24T14:14:00.000Z Eli Lilly inks $3.35 B China partnership as Immunovant halts lupus drug trial https://pharmadog.xyz/news/450434 pharmadog en 2026-09-24T14:10:00.000Z FDA nominee Heidi Overton affirms safety of vaccines and mifepristone in Senate hearing https://pharmadog.xyz/news/449447 pharmadog en 2026-09-24T13:52:10.000Z Kyverna reports durable responses in early cell therapy trial for autoimmune disease https://pharmadog.xyz/news/449427 pharmadog en 2026-09-24T13:51:12.000Z Merck’s eye-drug matches Lucentis in vision improvement but raises safety concerns https://pharmadog.xyz/news/449428 pharmadog en 2026-09-24T13:27:54.000Z Kyverna reports one-year mobility gains and safety for CAR-T miv-cel in stiff-person syndrome, bolstering FDA filing plans https://pharmadog.xyz/news/449448 pharmadog en 2026-09-24T13:21:50.000Z FDA nominee Heidi Overton pledges faster, more efficient regulation to keep pace with China https://pharmadog.xyz/news/449449 pharmadog en 2026-09-24T13:21:14.000Z Radiology startups say owning clinics speeds AI tool development as insurers resist new RPM rules https://pharmadog.xyz/news/449429 pharmadog en 2026-09-24T13:20:58.000Z FDA approves Eli Lilly’s weekly insulin Onswik for U.S. patients, expanding competition with Novo https://pharmadog.xyz/news/449430 pharmadog en 2026-09-24T12:59:32.000Z Basecamp Research secures $140 million Series C to accelerate AI-designed drug pipeline https://pharmadog.xyz/news/449259 pharmadog en 2026-09-24T12:43:58.000Z Roche signs up to $2 billion partnership with Atavistik to develop cardiometabolic drugs https://pharmadog.xyz/news/449127 pharmadog en 2026-09-24T12:14:05.000Z Merck's $1.3B EyeBio investment yields first ophthalmology success https://pharmadog.xyz/news/449151 pharmadog en 2026-09-24T12:12:54.000Z Eli Lilly earmarks up to $3.25 billion for partnership with InnoCare Pharma https://pharmadog.xyz/news/449003 pharmadog en 2026-09-24T11:52:28.000Z Measles deaths rise as U.S. sees worst outbreak since 1991, CDC reports four fatalities in Pennsylvania https://pharmadog.xyz/news/448835 pharmadog en 2026-09-24T10:30:00.000Z Gilead pushes further into immunology, touts inflammation drug pipeline https://pharmadog.xyz/news/448815 pharmadog en 2026-09-24T10:18:51.000Z Radioligand therapy gains momentum as experts discuss expanding patient impact https://pharmadog.xyz/news/449714 pharmadog en 2026-09-24T10:03:00.000Z Henlius Biotech signs $440 million deal with Amberstone to develop T-cell engagers https://pharmadog.xyz/news/448791 pharmadog en 2026-09-24T10:02:50.000Z Kyverna reports positive one-year CAR-T results for rare stiff person syndrome, supporting FDA filing https://pharmadog.xyz/news/448623 pharmadog en 2026-09-24T09:59:27.000Z Eli Lilly partners with China’s InnoCare on drug development deal worth up to $3.35 billion https://pharmadog.xyz/news/449715 pharmadog en 2026-09-24T09:46:00.000Z Acadia misses mark in Alzheimer’s but concludes phase 3 ‘absolutely worth’ pursuing https://pharmadog.xyz/news/448504 pharmadog en 2026-09-24T08:30:00.000Z Physician who survived measles warns of rising U.S. cases and deaths https://pharmadog.xyz/news/448503 pharmadog en 2026-09-24T08:30:00.000Z Heidi Overton, Trump’s FDA nominee, to appear before Senate committee for confirmation hearing https://pharmadog.xyz/news/448502 pharmadog en 2026-09-24T08:30:00.000Z Trump administration claims all states will join Medicaid drug pricing program, but several states remain undecided https://pharmadog.xyz/news/448505 pharmadog en 2026-09-24T08:30:00.000Z Novartis and Novo Nordisk trials lower biomarkers but fail to cut heart events, prompting preventive cardiology rethink https://pharmadog.xyz/news/448499 pharmadog en 2026-09-24T08:30:00.000Z Heidi Overton, a New Mexico-born physician, nominated as FDA commissioner https://pharmadog.xyz/news/448500 pharmadog en 2026-09-24T08:30:00.000Z Radiology practices increasingly develop and market in-house AI, branding themselves as AI-native https://pharmadog.xyz/news/448501 pharmadog en 2026-09-24T08:30:00.000Z Congress mulls linking Medicare doctor pay to medical inflation under Patients First Act https://pharmadog.xyz/news/449211 pharmadog en 2026-09-24T08:15:00.000Z Merck sees pivotal victory for $3B eye disease prospect https://pharmadog.xyz/news/449210 pharmadog en 2026-09-24T08:10:00.000Z Roche signs $2 billion deal with Atavistik to discover allosteric cardiovascular-renal-metabolic drugs https://pharmadog.xyz/news/449213 pharmadog en 2026-09-24T08:05:00.000Z Adagio Medical begins strategic review and cuts over half its workforce amid Nasdaq delisting risk https://pharmadog.xyz/news/447699 pharmadog en 2026-09-24T04:01:00.000Z AI-driven interviews risk alienating biotech and pharma job seekers, experts warn https://pharmadog.xyz/news/450394 pharmadog en 2026-09-24T04:00:00.000Z Abiomed issues recall of Automated Impella Controllers over purge cassette detection issue https://pharmadog.xyz/news/447700 pharmadog en 2026-09-24T04:00:00.000Z Series B funded biotechs expand hiring, Tenpoint Therapeutics raises $85M for eye-health pipeline https://pharmadog.xyz/news/448262 pharmadog en 2026-09-24T02:39:00.000Z Eli Lilly commits $100M upfront in new five-target partnership with China's InnoCare https://pharmadog.xyz/news/449378 pharmadog en 2026-09-24T02:00:00.000Z Grail's Galleri blood test receives positive FDA advisory panel vote, moving closer to approval https://pharmadog.xyz/news/446771 pharmadog en 2026-09-23T23:26:01.000Z White House plan to tighten control over NIH grants stalls after bipartisan opposition https://pharmadog.xyz/news/446495 pharmadog en 2026-09-23T22:14:37.000Z FDA nominee Heidi Overton pledges faster drug trials to keep US biotech competitive https://pharmadog.xyz/news/446327 pharmadog en 2026-09-23T21:47:58.000Z FDA advisory panel backs Grail's Galleri multi-cancer blood test, citing benefits outweigh risks https://pharmadog.xyz/news/446406 pharmadog en 2026-09-23T21:02:00.000Z Berlin Seeds recalls 950 lbs of alfalfa sprouting seed over possible STEC and Salmonella contamination https://pharmadog.xyz/news/446366 pharmadog en 2026-09-23T19:50:17.000Z Federal Court Issues Consent Decree Halting Gold Star Distribution's FDA-Regulated Shipments Over Unsanitary Warehouse https://pharmadog.xyz/news/445671 pharmadog en 2026-09-23T18:23:52.000Z FDA panel questions effectiveness of Grail's early-cancer detection test https://pharmadog.xyz/news/445672 pharmadog en 2026-09-23T18:05:52.000Z World's first personalized gene-editing therapy costs $1.65 million per patient, project director says https://pharmadog.xyz/news/445735 pharmadog en 2026-09-23T17:55:00.000Z AI-driven biotech Enveda secures $311 million Series E to advance plant-derived drug candidates https://pharmadog.xyz/news/445291 pharmadog en 2026-09-23T16:21:56.000Z Roche and Ionis report positive Phase 3 interim results for IgA nephropathy drug sefaxersen https://pharmadog.xyz/news/448766 pharmadog en 2026-09-23T16:18:00.000Z Kyverna reports year-long efficacy and clean safety for miv-cel CAR-T in autoimmune trials https://pharmadog.xyz/news/445059 pharmadog en 2026-09-23T15:46:09.000Z Former Changsheng biotech chair sentenced to life in prison over Chinese rabies vaccine scandal https://pharmadog.xyz/news/445060 pharmadog en 2026-09-23T15:21:54.000Z Enveda secures $311 million in third consecutive megaround to advance discovery and weight-maintenance programs https://pharmadog.xyz/news/445083 pharmadog en 2026-09-23T15:15:46.000Z Immunovant halts lupus program after Phase 2b trial fails to meet efficacy endpoints https://pharmadog.xyz/news/445123 pharmadog en 2026-09-23T15:13:51.000Z European pharma CEOs warn of biotech decline as R&D share drops to 31% and call for faster trials and stronger IP protection https://pharmadog.xyz/news/444891 pharmadog en 2026-09-23T14:49:59.000Z Roivant's FcRn drug IMVT-1402 fails Phase 2b lupus trial https://pharmadog.xyz/news/444915 pharmadog en 2026-09-23T14:31:29.000Z AI drug hunter Enveda raises $311M for late-stage obesity, inflammatory disease push https://pharmadog.xyz/news/444747 pharmadog en 2026-09-23T13:50:40.000Z Amgen's Sjögren's drug dazodalibep meets primary endpoint in Phase 3 trial https://pharmadog.xyz/news/444748 pharmadog en 2026-09-23T13:46:25.000Z Roche and Ionis report Phase 3 success for RNA therapy sefaxersen in IgA nephropathy https://pharmadog.xyz/news/444767 pharmadog en 2026-09-23T13:37:36.000Z Flagship Pioneering secures Pentagon contract to develop biological threat countermeasures https://pharmadog.xyz/news/444723 pharmadog en 2026-09-23T13:30:23.000Z Family’s struggle to receive cystic fibrosis medication highlights care gaps https://pharmadog.xyz/news/444768 pharmadog en 2026-09-23T13:29:58.000Z STAT AI Prognosis newsletter tackles AI doomerism and offers guidance for health professionals https://pharmadog.xyz/news/134233 pharmadog en 2026-09-23T13:23:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/444769 pharmadog en 2026-09-23T13:20:31.000Z US to End Personal Medication Import Loophole as New Customs Rule Takes Effect https://pharmadog.xyz/news/444750 pharmadog en 2026-09-23T13:17:51.000Z Novartis signs up to $900 million deal with China's BoomRay for preclinical radioligand therapy https://pharmadog.xyz/news/444724 pharmadog en 2026-09-23T13:00:00.000Z AI startup Basecamp Research secures $140 million Series C funding and outlines six-program AI pipeline https://pharmadog.xyz/news/444579 pharmadog en 2026-09-23T12:43:29.000Z Ionis and Otsuka's RNA therapy Ulefnersen shows functional and survival gains in rare FUS-ALS in Phase 3 trial https://pharmadog.xyz/news/444323 pharmadog en 2026-09-23T11:51:43.000Z US HHS and FDA announce new rules to expand non-animal testing methods as legal battles over youth gender-affirming care continue https://pharmadog.xyz/news/123087 pharmadog en 2026-09-23T11:31:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/444111 pharmadog en 2026-09-23T10:18:53.000Z Roche reports positive interim Phase 3 results for kidney drug, paving way for accelerated approval https://pharmadog.xyz/news/444135 pharmadog en 2026-09-23T10:11:39.000Z Novo outlines $23B revenue goal, cuts 4,000 jobs and expands Wegovy manufacturing amid investor skepticism https://pharmadog.xyz/news/444867 pharmadog en 2026-09-23T09:54:00.000Z Trump's Department of War bets $47M on Flagship biotechs to develop countermeasures https://pharmadog.xyz/news/444866 pharmadog en 2026-09-23T09:47:00.000Z Enveda Biosciences raises $311 million in Series E to accelerate nature-derived drug development https://pharmadog.xyz/news/444698 pharmadog en 2026-09-23T09:00:00.000Z Immunovant halts cutaneous lupus program after phase 2 failure https://pharmadog.xyz/news/444699 pharmadog en 2026-09-23T08:57:00.000Z Boehringer Ingelheim boosts Variant Bio partnership with $250 million for cardiovascular research https://pharmadog.xyz/news/443819 pharmadog en 2026-09-23T08:30:00.000Z Insurers UnitedHealth, CVS, and Kaiser oppose Medicare's contractor ban on remote patient monitoring https://pharmadog.xyz/news/443821 pharmadog en 2026-09-23T08:30:00.000Z Opinion: Mentally ill women need stronger support to become mothers https://pharmadog.xyz/news/443820 pharmadog en 2026-09-23T08:30:00.000Z FDA shift sparks renewed pharma and VC focus on osteoporosis drug development https://pharmadog.xyz/news/443822 pharmadog en 2026-09-23T08:30:00.000Z Quorum Health moves to nonprofit status as its rural hospital chain faces insolvency https://pharmadog.xyz/news/443632 pharmadog en 2026-09-23T07:00:00.000Z Job postings in Pennsylvania’s biopharma sector surge 213% as nine companies ramp up hiring https://pharmadog.xyz/news/443631 pharmadog en 2026-09-23T07:00:00.000Z Pharma companies compete for scarce manufacturing talent as reshoring ramps up https://pharmadog.xyz/news/443019 pharmadog en 2026-09-23T04:18:00.000Z ReCode Therapeutics appoints Heather Clark as CEO to lead cystic fibrosis and primary ciliary dyskinesia programs https://pharmadog.xyz/news/443020 pharmadog en 2026-09-23T04:12:00.000Z China’s $522 bn biotech push fuels US competition and partnership opportunities https://pharmadog.xyz/news/445942 pharmadog en 2026-09-23T04:00:00.000Z FDA issues early alert on Abiomed Impella controller safety issue https://pharmadog.xyz/news/445943 pharmadog en 2026-09-23T04:00:00.000Z FDA issues early alert on React Health VOCSN ventilators over connector fault https://pharmadog.xyz/news/443582 pharmadog en 2026-09-23T03:35:00.000Z Roche reports phase 3 success for sefaxersen in IgA nephropathy, eyes accelerated approval https://pharmadog.xyz/news/446525 pharmadog en 2026-09-23T00:00:00.000Z Industry groups back FDA’s proposed distributed manufacturing rule, seek clarification on implementation